The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including:
- Developing and submitting recommendations for the Texas Medicaid preferred drug list
- Suggesting clinical prior authorizations on outpatient prescription drugs.
- Recommending educational interventions for Medicaid providers.
- Reviewing drug utilization across the Medicaid program.
April 23, 2020
Temporary Change in Status for the Stimulants Drug Class
April 15, 2020
April 2020 NDC-to-HCPCS Crosswalk Now Available
April 10, 2020
RSV Season and Synagis Prior Authorization Ends April 14